Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited)

v3.23.2
Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current assets    
Cash $ 10,944,242 $ 13,468,026
Non-current assets    
Acquired patents, net 7,197 9,003
Total assets 10,951,439 13,477,029
Current liabilities    
Accounts payable & accrued interest 300,463 220,845
Unreimbursed expenses 1,083 42,060
Total current liabilities 301,546 262,905
Total liabilities 301,546 262,905
Stockholders’ equity    
Common stock, $0.001 par value; 100,000,000 shares authorized; 12,848,165 shares issued and outstanding as of June 30, 2023 and December 31, 2022 12,848 12,848
Additional paid-in capital 55,863,086 54,674,042
Accumulated deficit (45,226,041) (41,472,766)
Total stockholders’ equity 10,649,893 13,214,124
Total liabilities and stockholders’ equity $ 10,951,439 $ 13,477,029